A Sustained Release Depot for Narcotic Antagonists
- 1 January 1974
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 30 (1) , 31-33
- https://doi.org/10.1001/archpsyc.1974.01760070019003
Abstract
A total of 175 mg of naltrexone monohydrate, suspended in small particles of a polylactide plastic (500 mg), was injected intramuscularly in dogs whose spinal cords had been transected at the T5-10 levels. This produced a level of blockade against the effects of morphine (1 mg/kg) on the flexor and skin twitch reflex and pupillary diameter for a duration of 21 to 29 days. In some instances levels of blockade could still be detected 33 days after administration. This preparation demonstrates the feasibility of a slow release form of a narcotic antagonist that may have value in the treatment of narcotic addicts.Keywords
This publication has 7 references indexed in Scilit:
- Naltrexone, an Antagonist for the Treatment of Heroin DependenceArchives of General Psychiatry, 1973
- Physiological parameters of morphine dependence in man—Tolerance, early abstinence, protracted abstinenceJournal of Psychiatric Research, 1969
- Effects of morphine, nalorphine, cyclazocine, and naloxone on the flexor reflexInternational Journal of Neuropharmacology, 1967
- Classical conditioning of a morphine abstinence phenomenon, reinforcement of opioid-drinking behavior and ?relapse? in morphine-addicted ratsPsychopharmacology, 1967
- The Use of the Polaroid CU Camera in PupillographyInternational Journal of the Addictions, 1967
- An experimental study in the treatment of narcotic addicts with cyclazocineClinical Pharmacology & Therapeutics, 1966
- Cyclazocine, a Long Acting Narcotic Antagonist: ITS Voluntary Acceptance as a Treatment Modality by Narcotics AbusersInternational Journal of the Addictions, 1966